Prostate Cancer—1000-Person Tool
The Canadian Task Force on Preventive Health Care recommends against screening for prostate cancer with the PSA test
- The CTFPHC found that the potential small benefit from PSA screening is outweighed by the potential significant harms of the screening and associated follow-up treatment.
- Men should understand that PSA screening may result in additional testing if the PSA level is raised.
- To save one life we would need to diagnose an additional 27 men with prostate cancer
Results of screening 1,000 men with the PSA test
What are my risks if I don’t get screened?
- Among men who are screened with the PSA test, the risk of dying from prostate cancer is 5 in 1,000
- Among men who are not screened with the PSA test, the risk of dying from prostate cancer is 6 in 1,000
Complications of treatment for prostate cancer
For every 1,000 men who receive treatment for prostate cancer:
- 114–214 will have short-term complications such as infections, additional surgeries, and blood transfusions
- 127–442 will experience long-term erectile dysfunction
- up to 178 will experience urinary incontinence
- 4–5 will die from complications of prostate cancer treatment
Statistics for benefits and harms were calculated from the European Randomized Study of Screening for Prostate Cancer (ERSPC).